Skip to main content

SFDA Rejects AI-Powered Diabetes Prediction Device for Failing Safety and Efficacy Standards

2025-07-02

The Saudi Food and Drug Authority (SFDA) has rejected a marketing authorization application in the Kingdom of Saudi Arabia for a software medical device designed to predict the likelihood of developing Type 2 diabetes within the next four years in adults over 18. This AI and machine learning-powered device, despite being marketed in some European countries, failed to meet the Kingdom's safety and efficacy requirements.

 

Other News

SFDA Approves Marketing Authorization for Advanced Brain-Stimulation Medical Device for Parkinson's Disease

2025-06-30

The Saudi Food and Drug Authority (SFDA) has approved the medical device marketing authorization (MDMA) for a device that uses advanced deep brain stimulation technology. The SFDA described this technology as a breakthrough in neurological therapy, as it enables physicians to adjust treatment procedures in real time based on live brain signals detected during therapy. This allows for the personalization of treatment using data and algorithms, adapting to the patient’s changing condition.

Other News

SFDA Addresses Dexcom Glucose Monitoring Device Defect, Confirms Limited Distribution in Saudi Arabia

2025-06-22

The Saudi Food and Drug Authority (SFDA) has identified a defect in some of the Dexcom Continuous Glucose Monitoring (CGM) devices. This issue prevents audio alerts from sounding when blood glucose levels fluctuate too low or too high.

Other News

SFDA Suspends Medical Device Imports from Manufacturer Following Quality Violations

2025-06-19

The Saudi Food and Drug Authority (SFDA) has suspended imports from an international medical device and supplies manufacturer. This action is part of its ongoing regulatory efforts to verify the safety of products under its supervision circulating in the Saudi market.

Other News

The SFDA Hajj Operations Center Offers Immediate Response to Reports and Maintains Coordination with Government Entities

2025-05-31

Operating around the clock, the Saudi Food and Drug Authority (SFDA), through its Hajj Operations Center, serves as a central point of contact to support field teams and ensure quick responses to reports throughout the Hajj season. This dedication aligns with the Authority's commitment to safeguarding the health and safety of pilgrims, reflecting the generous care extended by our wise leadership towards the pilgrims and their unwavering concern for their comfort and well-being.

Other News

The SFDA CEO Reviews Field Preparedness for Hajj Season

2025-05-29

As part of the Authority's ongoing efforts to ensure the safety and well-being of pilgrims, H.E. Prof. Dr. Hisham S. Aljadhey, Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), conducted a field visit to the SFDA office in Makkah. The visit aimed to assess the implementation of operational plans for the 2025 Hajj season and confirm the readiness of services provided by the Authority to support a safe and healthy pilgrimage.

Other News

The SFDA Intensifies Warehouse Oversight as Part of Comprehensive Plan for Hajj 2025

2025-05-24

As part of its comprehensive preparations for the Hajj season 2025, the Saudi Food and Drug Authority (SFDA) has intensified its proactive inspection efforts, conducting over 1,329 field visits to food, pharmaceutical, and medical device warehouses in the Makkah and Madinah regions. This aligns with the remarkable compliance rates observed in facilities storing food and medicine, a direct result of ongoing inspections and awareness-raising efforts that have reinforced their commitment to the requirements.

Other News

The SFDA Launches Awareness Campaign for Safe Use of Home Medical Devices

2025-05-20

The Saudi Food and Drug Authority (SFDA) has launched a digital awareness campaign to educate the public on the safe and proper use of medical devices and supplies intended for home use. This campaign aligns with the SFDA's ongoing commitment to public health and is a key component of its fourth strategic plan.

Other News

The SFDA Begins Field Inspection Tours as Part of the Hajj Season Preparations

2025-05-15

As part of its early and comprehensive preparations for the Hajj season 2025, the Saudi Food and Drug Authority (SFDA) has launched a series of field inspection tours across key locations and facilities. The purpose is to assess the state of readiness of the inspection teams and to monitor the implementation of approved plans, with the aim of protecting the health and safety of pilgrims by ensuring the highest standards of food, drug, and medical product safety.

Other News

The SFDA: Leveraging Modern Technology for Enhanced Hajj Inspection Efficiency

2025-05-03

The Saudi Food and Drug Authority (SFDA) is continuously advancing its regulatory framework and boosting its operational effectiveness. This aligns with the Health Sector Transformation Program, a key pillar of Saudi Vision 2030.

During the Hajj season, the SFDA intensifies its focus on employing technologies to protect pilgrim health and safety by providing top-tier quality control and regulatory services that meet the highest standards.

Other News

Subscribe to Medical Devices